What is Next Generation Sequencing?
Next-generation sequencing (NGS) is a high-throughput methodology that enables rapid sequencing of the base pairs in DNA or RNA samples. Supporting a broad range of applications, including gene expression profiling, chromosome counting, detection of epigenetic changes, and molecular analysis, NGS is driving discovery and enabling the future of personalized medicine. Granger Genetics employs the most current technology to deliver accurate and reliable results to clinicians. Utilizing Next Generation Sequencing, we have optimized the diagnosis of infectious diseases by employing the most advanced laboratory processes designed and built by experts with more than 30 years of experience in the field. This ensures rapid through-put and maximum accuracy in diagnosis.
Assay for Leukemia Patients
The L-asparaginase assay is a laboratory developed test (LDT) to determine the enzyme activity of L-asparaginase in patients who have been treated with Elspar®/Kidrolase®, Oncaspar®, or Erwinaze®.
Granger Genetics has earned The Joint Commission’s Gold Seal of Approval® for Laboratory Services Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.